With a primary focus on Anti-Diabetic Drugs, a rapidly growing therapeutic segment, Auro Laboratories currently produces Metformin Hydrochloride and Glibenclamide, with plans to introduce additional drugs in this category. Moreover, they offer Toll/Custom Manufacturing services for APIs and Intermediates on a contract basis. Operating in accordance with cGMP norms, their manufacturing facility boasts an annual capacity exceeding 500 tonnes.
Auro Laboratories has established a significant presence in international markets, exporting a majority of its production to South East Asia, the Middle East, and various European countries such as Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom.
The company holds ISO 9001:2000 and WHO - cGMP certifications, along with a CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) received in September 2006.